Evidence map›Paper›PMID 34861219›Full record

ArticleGastroenterology2022

γδ Intraepithelial Lymphocytes Facilitate Pathological Epithelial Cell Shedding Via CD103-Mediated Granzyme Release.

Madeleine D Hu, Natasha B Golovchenko, Grace L Burns, Prema M Nair, Thomas J Kelly, Jonathan Agos, Mudar Zand Irani, Wai Sinn Soh, Matthew R Zeglinski, Alexander Lemenze and 7 more

Open access · bronzeAbstract read
In one paragraph

Article in Gastroenterology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
2.8field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 44 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. γδ T cells: origin and fate, subsets, diseases and immunotherapy.Signal transduction and targeted therapy · 2023
    Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 6 institutions in 5 countries.

Madeleine D HuCenter for Immunity and Inflammation, Department of Pathology, Immunology and Laboratory Medicine, Rutgers New Jersey Medical School, Newark, New Jersey.
Natasha B GolovchenkoCenter for Immunity and Inflammation, Department of Pathology, Immunology and Laboratory Medicine, Rutgers New Jersey Medical School, Newark, New Jersey.
Grace L BurnsNational Health and Medical Research Council Centre of Research Excellence in Digestive Health, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, New South Wales, Australia, Hunter Medical Research Institute, New Lambton Heights, New South Wales, Australia.
Prema M NairNational Health and Medical Research Council Centre of Research Excellence in Digestive Health, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, New South Wales, Australia, Hunter Medical Research Institute, New Lambton Heights, New South Wales, Australia.
Thomas J KellyCenter for Immunity and Inflammation, Department of Pathology, Immunology and Laboratory Medicine, Rutgers New Jersey Medical School, Newark, New Jersey.
Jonathan AgosCenter for Immunity and Inflammation, Department of Pathology, Immunology and Laboratory Medicine, Rutgers New Jersey Medical School, Newark, New Jersey.
Mudar Zand IraniNational Health and Medical Research Council Centre of Research Excellence in Digestive Health, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, New South Wales, Australia, Hunter Medical Research Institute, New Lambton Heights, New South Wales, Australia.
Wai Sinn SohNational Health and Medical Research Council Centre of Research Excellence in Digestive Health, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, New South Wales, Australia, Hunter Medical Research Institute, New Lambton Heights, New South Wales, Australia.
Matthew R ZeglinskiDepartment of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
Alexander LemenzeCenter for Immunity and Inflammation, Department of Pathology, Immunology and Laboratory Medicine, Rutgers New Jersey Medical School, Newark, New Jersey.
Edward M BonderDepartment of Biological Sciences, Rutgers University, The State University of New Jersey, Newark, New Jersey.
Inga SandrockInstitute of Immunology, Hannover Medical School, Hannover, Germany.
Immo PrinzInstitute of Systems Immunology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
David J GranvilleDepartment of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
Simon KeelyNational Health and Medical Research Council Centre of Research Excellence in Digestive Health, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, New South Wales, Australia, Hunter Medical Research Institute, New Lambton Heights, New South Wales, Australia.
Alastair J M WatsonDepartment of Gastroenterology and Gut Biology, Norwich Medical School, University of East Anglia, Norwich, UK.
Karen L EdelblumCenter for Immunity and Inflammation, Department of Pathology, Immunology and Laboratory Medicine, Rutgers New Jersey Medical School, Newark, New Jersey. Electronic address: ke163@njms.rutgers.edu.
Rutgers, The State University of New Jersey · USHunter Medical Research Institute · AUUniversity of British Columbia · CAMedizinische Hochschule Hannover · DEUniversität Hamburg · DEUniversity of East Anglia · GB

Funding

Program in Infection, Immunity and InflammationT32AI125185 · NIAID · RBHS-NEW JERSEY MEDICAL SCHOOL · PI SALGAME, PADMINI · 2016 to 2020
$747k
BD FACSAria II for NJMS Flow Cytometry CoreS10RR027022 · NCRR · UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL · PI FITZGERALD-BOCARSLY, PATRICIA · 2011 to 2011
$501k
Intraepithelial lymphocyte regulation of epithelial cell sheddingR21AI143892 · NIAID · RBHS-NEW JERSEY MEDICAL SCHOOL · PI EDELBLUM, KAREN LEIGH · 2019 to 2020
$426k
Mechanisms of gamma delta intraepithelial lymphocyte-mediated host defenseF30DK121391 · NIDDK · RBHS-NEW JERSEY MEDICAL SCHOOL · PI HU, MADELEINE · 2019 to 2020
$77k
CIHRMedical Research Council G9900432NCRR NIH HHS S10 RR027022NIAID NIH HHS R21 AI143892NIAID NIH HHS T32 AI125185NIDDK NIH HHS F30 DK121391
6 · The paper itself

Abstract

BACKGROUND &

aimsExcessive shedding of apoptotic enterocytes into the intestinal lumen is observed in inflammatory bowel disease and is correlated with disease relapse. Based on their cytolytic capacity and surveillance behavior, we investigated whether intraepithelial lymphocytes expressing the γδ T cell receptor (γδ IELs) are actively involved in the shedding of enterocytes into the lumen.

methodsIntravital microscopy was performed on GFP γδ T cell reporter mice treated with intraperitoneal lipopolysaccharide (10 mg/kg) for 90 minutes to induce tumor necrosis factor-mediated apoptosis. Cell shedding in various knockout or transgenic mice in the presence or absence of blocking antibody was quantified by immunostaining for ZO-1 funnels and cleaved caspase-3 (CC3). Granzyme A and granzyme B release from ex vivo-stimulated γδ IELs was quantified by enzyme-linked immunosorbent assay. Immunostaining for γδ T cell receptor and CC3 was performed on duodenal and ileal biopsies from controls and patients with Crohn's disease.

resultsIntravital microscopy of lipopolysaccharide-treated mice revealed that γδ IELs make extended contact with shedding enterocytes. These prolonged interactions require CD103 engagement by E-cadherin, and CD103 knockout or blockade significantly reduced lipopolysaccharide-induced shedding. Furthermore, we found that granzymes A and B, but not perforin, are required for cell shedding. These extracellular granzymes are released by γδ IELs both constitutively and after CD103/E-cadherin ligation. Moreover, we found that the frequency of γδ IEL localization to CC3-positive enterocytes is increased in Crohn's disease biopsies compared with healthy controls.

conclusionsOur results uncover a previously unrecognized role for γδ IELs in facilitating tumor necrosis factor-mediated shedding of apoptotic enterocytes via CD103-mediated extracellular granzyme release.

Indexed as

AdolescentAdultAnimalsAntigens, CDApoptosisCadherinsCaspase 3Crohn DiseaseDuodenumEnterocytesFemaleGene Knockdown TechniquesGranzymesHumansIleumIntegrin alpha Chainsalpha E integrinsAntigens, CDCadherinsCaspase 3granzyme A, mouseGranzymesGzmb protein, mouseIntegrin alpha ChainsLipopolysaccharidesReceptors, Antigen, T-Cell, gamma-deltaTumor Necrosis Factor-alphaCell ExtrusionGamma Delta T CellsMucosal Immunology

Identifiers

PMID34861219
PMCPMC8881348
OpenAlexW3217529080

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.